Acetaminophen, Phenacetin and Dipyrone Do Not Modulate Pressor Responses to Arachidonic Acid or to Pressor Agents
暂无分享,去创建一个
[1] Yun‐Sil Lee,et al. Acetaminophen selectively suppresses peripheral prostaglandin E2 release and increases COX-2 gene expression in a clinical model of acute inflammation , 2007, PAIN.
[2] D. Busija,et al. Cloning of cyclooxygenase-1b (putative COX-3) in mouse , 2006, Inflammation Research.
[3] Sui-Po Zhang,et al. Cloning, Expression, and Functional Characterization of Human Cyclooxygenase-1 Splicing Variants: Evidence for Intron 1 Retention , 2005, Journal of Pharmacology and Experimental Therapeutics.
[4] D. Busija,et al. Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties , 2005, Journal of Pharmacology and Experimental Therapeutics.
[5] P. Neuvonen,et al. Dose-dependent Inhibition of Platelet Function by Acetaminophen in Healthy Volunteers , 2005, Anesthesiology.
[6] J. N. Sharma,et al. Adverse Effects of COX-2 Inhibitors , 2005, TheScientificWorldJournal.
[7] E. Lally,et al. Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?* , 2005, Current medical research and opinion.
[8] M. Silvanto,et al. Characterization of inhibition of platelet function by paracetamol and its interaction with diclofenac in vitro , 2005, Acta anaesthesiologica Scandinavica.
[9] G. S. Shelness,et al. Cloning and Characterization of Cyclooxygenase-1b (Putative Cyclooxygenase-3) in Rat , 2005, Journal of Pharmacology and Experimental Therapeutics.
[10] J. Mitchell,et al. Cellular mechanisms of acetaminophen: role of cyclo‐oxygenase , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] D. Busija,et al. Acetaminophen-sensitive prostaglandin production in rat cerebral endothelial cells. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.
[12] R. Gryglewski,et al. In vivo endothelial interaction between ACE and COX inhibitors. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.
[13] G. Graham,et al. Mechanism of Action of Paracetamol , 2005, American journal of therapeutics.
[14] S. Ferreira,et al. Analgesic and antiinflammatory effects of dipyrone in rat adjuvant arthritis model , 1994, Inflammation.
[15] Y. Jiao,et al. Nociception and the differential expression of cyclooxygenase-1 (COX-1), the COX-1 variant retaining intron-1 (COX-1v), and COX-2 in mouse dorsal root ganglia (DRG). , 2004, Prostaglandins & other lipid mediators.
[16] J. Mitchell,et al. Cyclooxygenases 1, 2, and 3 and the Production of Prostaglandin I2: Investigating the Activities of Acetaminophen and Cyclooxygenase-2-Selective Inhibitors in Rat Tissues , 2004, Journal of Pharmacology and Experimental Therapeutics.
[17] R. Botting,et al. Acetaminophen-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[18] N. Davies,et al. Cyclooxygenase-3: axiom, dogma, anomaly, enigma or splice error?--Not as easy as 1, 2, 3. , 2004, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[19] G. FitzGerald. Prostaglandins: Modulators of Inflammation and Cardiovascular Risk , 2004, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[20] J. Mitchell,et al. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] F. Fitzpatrick,et al. Cyclooxygenase enzymes: regulation and function. , 2004, Current pharmaceutical design.
[22] M. Respondek,et al. Interaction of Cyclooxygenase Isoenzymes, Nitric Oxide, and Afferent Neurons in Gastric Mucosal Defense in Rats , 2004, Journal of Pharmacology and Experimental Therapeutics.
[23] G. Graham,et al. Mechanisms of action of paracetamol and related analgesics , 2004, InflammoPharmacology.
[24] P. Kadowitz,et al. Role of COX-1 and -2 in prostanoid generation and modulation of angiotensin II responses. , 2003, American journal of physiology. Heart and circulatory physiology.
[25] M. O’Banion,et al. COX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells. , 2003, Brain research. Molecular brain research.
[26] D. Busija,et al. Putative Cyclooxygenase-3 Expression in Rat Brain Cells , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[27] P. Rosenberg,et al. Propacetamol augments inhibition of platelet function by diclofenac in volunteers. , 2003, British journal of anaesthesia.
[28] T. Bivalacqua,et al. Role of Cyclooxygenase-2 in the Generation of Vasoactive Prostanoids in the Rat Pulmonary and Systemic Vascular Beds , 2003, Circulation.
[29] H. Vapaatalo,et al. Effects of phenacetin and its metabolite p-phenetidine on COX-1 and COX-2 activities and expression in vitro. , 2003, Thrombosis research.
[30] J. Vane,et al. The mechanism of action of aspirin. , 2003, Thrombosis research.
[31] E. Ricciotti,et al. Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells , 2003, British journal of pharmacology.
[32] N. V. Chandrasekharan,et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[33] Ferreira Sh. Peripheral analgesic sites of action of anti-inflammatory drugs. , 2002 .
[34] J. Morrow,et al. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. , 2002, The Journal of clinical investigation.
[35] R. I. Graham,et al. Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol). , 2002, Current pharmaceutical design.
[36] T. Saruta,et al. Stenosis-dependent role of nitric oxide and prostaglandins in chronic renal ischemia. , 2002, American journal of physiology. Renal physiology.
[37] S. Ferreira. Peripheral analgesic sites of action of anti-inflammatory drugs. , 2002, International journal of clinical practice. Supplement.
[38] M. Lettino,et al. Cyclo-exygenase-1 and cyclo-oxygenase-2 and cardiovascular vascular system , 2001 .
[39] Elizabeth Murphy,et al. Cyclooxygenase-1 and -2 Knockout Mice Demonstrate Increased Cardiac Ischemia/Reperfusion Injury but Are Protected by Acute Preconditioning , 2001, Circulation.
[40] M. Breyer,et al. Physiological regulation of cyclooxygenase-2 in the kidney. , 2001, American journal of physiology. Renal physiology.
[41] M. Ross,et al. Cyclooxygenase-1 Participates in Selected Vasodilator Responses of the Cerebral Circulation , 2001, Circulation research.
[42] M. Percival,et al. Mechanism of acetaminophen inhibition of cyclooxygenase isoforms. , 2001, Archives of biochemistry and biophysics.
[43] M. Lettino,et al. Cyclo-oxygenase-1 and cyclo-oxygenase-2 and cardiovascular system. , 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[44] R. Botting. Paracetamol-inhibitable COX-2. , 2000, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[45] R. Botting,et al. Mechanism of action of acetaminophen: is there a cyclooxygenase 3? , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] K. Hellemans,et al. Phenacetin, acetaminophen and dipyrone: analgesic and rewarding effects , 2000, Behavioural Brain Research.
[47] L. Dwyer-Nield,et al. High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. , 2000, Carcinogenesis.
[48] R. Garavito,et al. The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins. , 1999, Biochimica et biophysica acta.
[49] P. Thompson,et al. Expression and localization of COX-2 in human airways and cultured airway epithelial cells. , 1999, The European respiratory journal.
[50] G. FitzGerald,et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. , 1999, The Journal of pharmacology and experimental therapeutics.
[51] D. Fitzgerald,et al. Selective cyclooxygenase-2 inhibition by nimesulide in man. , 1998, The Journal of pharmacology and experimental therapeutics.
[52] C. Koboldt,et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[53] W. Seeger,et al. Vasoregulatory prostanoid generation proceeds via cyclooxygenase-2 in noninflamed rat lungs. , 1998, The Journal of pharmacology and experimental therapeutics.
[54] W. Seeger,et al. Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. , 1998, American journal of respiratory cell and molecular biology.
[55] J. Vane,et al. Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.
[56] H. Champion,et al. Responses to angiotensin peptides are mediated by AT1 receptors in the rat. , 1998, American journal of physiology. Endocrinology and metabolism.
[57] H. Chan,et al. PROSTANOID ACTION ON THE HUMAN PULMONARY VASCULAR SYSTEM , 1997, Clinical and experimental pharmacology & physiology.
[58] D. Riendeau,et al. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. , 1997, Canadian journal of physiology and pharmacology.
[59] P Netter,et al. Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs. , 1997, Drugs.
[60] J. Grose,et al. Eicosanoid modulation of the norepinephrine effect on blood pressure and renal hemodynamics in humans. , 1996, Prostaglandins, leukotrienes, and essential fatty acids.
[61] P. D. de Leeuw. Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective. , 1996, Drugs.
[62] A. Kaye,et al. Analysis of responses to ANG IV: effects of PD-123319 and DuP-753 in the pulmonary circulation of the rat. , 1995, The American journal of physiology.
[63] J. Wood,et al. Role of prostaglandins in angiotensin II-induced gastric vasoconstriction. , 1994, The American journal of physiology.
[64] Y. Xia,et al. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. , 1993, Archives of biochemistry and biophysics.
[65] B. Giusti,et al. Cyclooxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophils: in vitro effect of dipyrone. , 1990, Prostaglandins, leukotrienes, and essential fatty acids.
[66] H. Weiss,et al. Inhibition of human platelet function in vitro and ex vivo by acetaminophen. , 1989, Thrombosis research.
[67] V. Drvota,et al. Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). , 1989, Prostaglandins.
[68] M. Yaron,et al. Nonsteroidal anti-inflammatory drugs, and hypertension. , 1988, Annals of internal medicine.
[69] J. Dupin,et al. In vitro antiaggregant activity of paracetamol and derivatives. , 1988, Thrombosis research.
[70] Frölich Jc,et al. The effects of metamizol on prostaglandin synthesis in man. , 1986 .
[71] J. Frölich,et al. The effects of metamizol on prostaglandin synthesis in man. , 1986, Agents and actions. Supplements.
[72] Peterson Rg. Consequences associated with nonnarcotic analgesics in the fetus and newborn. , 1985 .
[73] M. Dunn,et al. The role of prostaglandins in human hypertension. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[74] R. Peterson. Consequences associated with nonnarcotic analgesics in the fetus and newborn. , 1985, Federation proceedings.
[75] A. Eldor,et al. Effects of Dipyrone on Prostaglandin Production by Human Platelets and Cultured Bovine Aortic Endothelial Cells , 1983, Thrombosis and Haemostasis.
[76] H. Vapaatalo,et al. Comparative study on the effects of acetylsalicylic acid, indomethacin and paracetamol on metabolites of arachidonic acid in plasma, serum and urine in man. , 1983, International journal of clinical pharmacology research.
[77] P. Kadowitz,et al. Dependence of the airway and pulmonary vascular effects of arachidonic acid upon route and rate of administration. , 1980, The Journal of pharmacology and experimental therapeutics.
[78] M. Caton,et al. Prostaglandins and thromboxanes. , 1979, Progress in medicinal chemistry.
[79] A. Mathé,et al. Modification of pulmonary vascular responses to arachidonic acid by alterations in physiologic state. , 1978, The Journal of pharmacology and experimental therapeutics.
[80] B. Samuelsson. Prostaglandins and Thromboxanes , 1977, NATO Advanced Study Institutes Series.
[81] P. Kadowitz,et al. Influence of inhibitors of prostaglandin synthesis on the canine pulmonary vascular bed. , 1975, The American journal of physiology.
[82] J. Vane,et al. Inhibition of Prostaglandin Synthetase in Brain explains the Anti-pyretic Activity of Paracetamol (4-Acetamidophenol) , 1972, Nature.